 | • レポートコード：B-GIR09D4106 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、黄斑変性症治療の世界市場について調べ、まとめました。種類別セグメントは、ルセンティス、アイリー、アバスチン、その他等、用途別セグメントは、病院、眼科、その他等に区分しました。黄斑変性症治療の世界市場概観、企業動向、企業別黄斑変性症治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・黄斑変性症治療の市場概観 ・黄斑変性症治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・黄斑変性症治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・黄斑変性症治療の世界市場規模 ・黄斑変性症治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・黄斑変性症治療のアメリカ市場規模推移 ・黄斑変性症治療のカナダ市場規模推移 ・黄斑変性症治療のメキシコ市場規模推移 ・黄斑変性症治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・黄斑変性症治療のドイツ市場規模推移 ・黄斑変性症治療のイギリス市場規模推移 ・黄斑変性症治療のロシア市場規模推移 ・黄斑変性症治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・黄斑変性症治療の日本市場規模推移 ・黄斑変性症治療の中国市場規模推移 ・黄斑変性症治療の韓国市場規模推移 ・黄斑変性症治療のインド市場規模推移 ・黄斑変性症治療の東南アジア市場規模推移 ・黄斑変性症治療の南米市場分析（ブラジル、アルゼンチン等） ・黄斑変性症治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・黄斑変性症治療の種類別分析/販売量、売上、市場シェア（ルセンティス、アイリー、アバスチン、その他） ・黄斑変性症治療の用途別分析/市場規模（病院、眼科、その他） ・黄斑変性症治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・黄斑変性症治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. Early on there are often no symptoms. Over time, however, some people experience a gradual worsening of vision that may affect one or both eyes. While it does not result in complete blindness, loss of central vision can make it hard to recognize faces, drive, read, or perform other activities of daily life. Visual hallucinations may also occur but these do not represent a mental illness.
Scope of the Report:
The global Macular Degeneration Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Macular Degeneration Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Macular Degeneration Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Macular Degeneration Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
Bausch Health Companies
Allergan
Novartis
Pfizer
Bayer
Roche
Sanofi
Santen Pharmaceuticals
Regeneron Pharmaceuticals
Kanghong Pharma
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Lucentis
Eylea
Avastin
Others
Market Segment by Applications, can be divided into
Hospitals
Eye Clinics
Others
Table of Contents
1 Macular Degeneration Treatment Market Overview
1.1 Product Overview and Scope of Macular Degeneration Treatment
1.2 Classification of Macular Degeneration Treatment by Types
1.2.1 Global Macular Degeneration Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Macular Degeneration Treatment Revenue Market Share by Types in 2018
1.2.3 Lucentis
1.2.4 Eylea
1.2.5 Avastin
1.2.6 Others
1.3 Global Macular Degeneration Treatment Market by Application
1.3.1 Global Macular Degeneration Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospitals
1.3.3 Eye Clinics
1.3.4 Others
1.4 Global Macular Degeneration Treatment Market by Regions
1.4.1 Global Macular Degeneration Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Macular Degeneration Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Macular Degeneration Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Macular Degeneration Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Macular Degeneration Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Macular Degeneration Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Macular Degeneration Treatment (2014-2024)
2 Manufacturers Profiles
2.1 Bausch Health Companies
2.1.1 Business Overview
2.1.2 Macular Degeneration Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bausch Health Companies Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Allergan
2.2.1 Business Overview
2.2.2 Macular Degeneration Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Allergan Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Macular Degeneration Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Macular Degeneration Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bayer
2.5.1 Business Overview
2.5.2 Macular Degeneration Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bayer Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Roche
2.6.1 Business Overview
2.6.2 Macular Degeneration Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Sanofi
2.7.1 Business Overview
2.7.2 Macular Degeneration Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Santen Pharmaceuticals
2.8.1 Business Overview
2.8.2 Macular Degeneration Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Santen Pharmaceuticals Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Regeneron Pharmaceuticals
2.9.1 Business Overview
2.9.2 Macular Degeneration Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Regeneron Pharmaceuticals Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Kanghong Pharma
2.10.1 Business Overview
2.10.2 Macular Degeneration Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Kanghong Pharma Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Macular Degeneration Treatment Market Competition, by Players
3.1 Global Macular Degeneration Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Macular Degeneration Treatment Players Market Share
3.2.2 Top 10 Macular Degeneration Treatment Players Market Share
3.3 Market Competition Trend
4 Global Macular Degeneration Treatment Market Size by Regions
4.1 Global Macular Degeneration Treatment Revenue and Market Share by Regions
4.2 North America Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
5 North America Macular Degeneration Treatment Revenue by Countries
5.1 North America Macular Degeneration Treatment Revenue by Countries (2014-2019)
5.2 USA Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
6 Europe Macular Degeneration Treatment Revenue by Countries
6.1 Europe Macular Degeneration Treatment Revenue by Countries (2014-2019)
6.2 Germany Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
6.4 France Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Macular Degeneration Treatment Revenue by Countries
7.1 Asia-Pacific Macular Degeneration Treatment Revenue by Countries (2014-2019)
7.2 China Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
7.5 India Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
8 South America Macular Degeneration Treatment Revenue by Countries
8.1 South America Macular Degeneration Treatment Revenue by Countries (2014-2019)
8.2 Brazil Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Macular Degeneration Treatment by Countries
9.1 Middle East and Africa Macular Degeneration Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
10 Global Macular Degeneration Treatment Market Segment by Type
10.1 Global Macular Degeneration Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Macular Degeneration Treatment Market Forecast by Type (2019-2024)
10.3 Lucentis Revenue Growth Rate (2014-2024)
10.4 Eylea Revenue Growth Rate (2014-2024)
10.5 Avastin Revenue Growth Rate (2014-2024)
10.6 Others Revenue Growth Rate (2014-2024)
11 Global Macular Degeneration Treatment Market Segment by Application
11.1 Global Macular Degeneration Treatment Revenue Market Share by Application (2014-2019)
11.2 Macular Degeneration Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2014-2019)
11.4 Eye Clinics Revenue Growth (2014-2019)
11.5 Others Revenue Growth (2014-2019)
12 Global Macular Degeneration Treatment Market Size Forecast (2019-2024)
12.1 Global Macular Degeneration Treatment Market Size Forecast (2019-2024)
12.2 Global Macular Degeneration Treatment Market Forecast by Regions (2019-2024)
12.3 North America Macular Degeneration Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Macular Degeneration Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Macular Degeneration Treatment Revenue Market Forecast (2019-2024)
12.6 South America Macular Degeneration Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Macular Degeneration Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Macular Degeneration Treatment Picture
Table Product Specifications of Macular Degeneration Treatment
Table Global Macular Degeneration Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Macular Degeneration Treatment Revenue Market Share by Types in 2018
Figure Lucentis Picture
Figure Eylea Picture
Figure Avastin Picture
Figure Others Picture
Table Global Macular Degeneration Treatment Revenue (Million USD) by Application (2014-2024)
Figure Macular Degeneration Treatment Revenue Market Share by Applications in 2018
Figure Hospitals Picture
Figure Eye Clinics Picture
Figure Others Picture
Table Global Market Macular Degeneration Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table Bausch Health Companies Basic Information, Manufacturing Base and Competitors
Table Bausch Health Companies Macular Degeneration Treatment Type and Applications
Table Bausch Health Companies Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Allergan Basic Information, Manufacturing Base and Competitors
Table Allergan Macular Degeneration Treatment Type and Applications
Table Allergan Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Macular Degeneration Treatment Type and Applications
Table Novartis Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Macular Degeneration Treatment Type and Applications
Table Pfizer Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Macular Degeneration Treatment Type and Applications
Table Bayer Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Macular Degeneration Treatment Type and Applications
Table Roche Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Macular Degeneration Treatment Type and Applications
Table Sanofi Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Santen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Santen Pharmaceuticals Macular Degeneration Treatment Type and Applications
Table Santen Pharmaceuticals Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Regeneron Pharmaceuticals Macular Degeneration Treatment Type and Applications
Table Regeneron Pharmaceuticals Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Kanghong Pharma Basic Information, Manufacturing Base and Competitors
Table Kanghong Pharma Macular Degeneration Treatment Type and Applications
Table Kanghong Pharma Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Macular Degeneration Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Macular Degeneration Treatment Revenue Share by Players (2014-2019)
Figure Global Macular Degeneration Treatment Revenue Share by Players in 2017
Figure Global Macular Degeneration Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Macular Degeneration Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Macular Degeneration Treatment Revenue Market Share in 2018
Figure Global Macular Degeneration Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Macular Degeneration Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Macular Degeneration Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Macular Degeneration Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Macular Degeneration Treatment Revenue Market Share by Regions in 2018
Figure North America Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure South America Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Table North America Macular Degeneration Treatment Revenue by Countries (2014-2019)
Table North America Macular Degeneration Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Macular Degeneration Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Macular Degeneration Treatment Revenue Market Share by Countries in 2018
Figure USA Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Table Europe Macular Degeneration Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Macular Degeneration Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Macular Degeneration Treatment Revenue Market Share by Countries in 2018
Figure Germany Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure UK Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure France Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Macular Degeneration Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Macular Degeneration Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Macular Degeneration Treatment Revenue Market Share by Countries in 2018
Figure China Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure India Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Table South America Macular Degeneration Treatment Revenue by Countries (2014-2019)
Table South America Macular Degeneration Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Macular Degeneration Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Macular Degeneration Treatment Revenue Market Share by Countries in 2018
Figure Brazil Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Macular Degeneration Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Macular Degeneration Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Macular Degeneration Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Macular Degeneration Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Macular Degeneration Treatment Revenue and Growth Rate (2014-2019)
Table Global Macular Degeneration Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Macular Degeneration Treatment Revenue Share by Type (2014-2019)
Figure Global Macular Degeneration Treatment Revenue Share by Type (2014-2019)
Figure Global Macular Degeneration Treatment Revenue Share by Type in 2019
Table Global Macular Degeneration Treatment Revenue Forecast by Type (2019-2024)
Figure Global Macular Degeneration Treatment Market Share Forecast by Type (2019-2024)
Figure Global Lucentis Revenue Growth Rate (2014-2019)
Figure Global Eylea Revenue Growth Rate (2014-2019)
Figure Global Avastin Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Macular Degeneration Treatment Revenue by Application (2014-2019)
Table Global Macular Degeneration Treatment Revenue Share by Application (2014-2019)
Figure Global Macular Degeneration Treatment Revenue Share by Application (2014-2019)
Figure Global Macular Degeneration Treatment Revenue Share by Application in 2019
Table Global Macular Degeneration Treatment Revenue Forecast by Application (2019-2024)
Figure Global Macular Degeneration Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospitals Revenue Growth Rate (2014-2019)
Figure Global Eye Clinics Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Figure Global Macular Degeneration Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Macular Degeneration Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Macular Degeneration Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Macular Degeneration Treatment Revenue Market Forecast (2019-2024)
Figure Europe Macular Degeneration Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Macular Degeneration Treatment Revenue Market Forecast (2019-2024)
Figure South America Macular Degeneration Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Macular Degeneration Treatment Revenue Market Forecast (2019-2024)
世界の網膜医薬品市場予測（～2024年） Retinal Pharmaceuticals is primarily used to treat retinal-related diseases. Retina is a layer of nerve tissue lining the back of the eye. Retina receives light and convert it into neural signals, and send these signals to the brain for visual recognition. The central part of the retina is known as …- 世界の腱炎治療市場予測（～2024年） Tendinitis is irritation or inflammation of a tendon, a thick cord that attaches muscle to bone. Tendinitis is also called tendonitis. Tendinitis mainly caused due to sudden injury or activities that put stress on the tendons. Scope of the Report: The global Tendinitis Treatment market is valued at …
- 世界の髄膜炎菌感染症治療市場予測（～2024年） Meningococcal meningitis are a major cause of bacterial meningitis and septicemia, usually occurs during infancy, adolescence and young adulthood and is characterized by an infectious syndrome with meningismus. Aggressive early treatment of meningococcal disease can reduce mortality. Scope of the Re…
- 世界のアナフィラキシー治療市場予測（～2024年） Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death. It typically causes more than one of the following: an itchy rash, throat or tongue swelling, shortness of breath, vomiting, lightheadedness, and low blood pressure. These symptoms typically come on over minutes t…
- 世界のレフサム病治療市場予測（～2024年） Refsum disease, also known as classic or adult Refsum disease, heredopathia atactica polyneuritiformis, phytanic acid oxidase deficiency and phytanic acid storage disease, is an autosomal recessive neurological disease that results in the over-accumulation of phytanic acid in cells and tissues. Scop…